LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM) — FDA Approval NDA210632 (FRESENIUS KABI USA)
LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM) — FDA Approval NDA210632 (FRESENIUS KABI USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LEVOTHYROXINE SODIUM; Active ingredients: LEVOTHYROXINE SODIUM; Application number: NDA210632.
| Brand name | LEVOTHYROXINE SODIUM |
|---|---|
| Active ingredients | LEVOTHYROXINE SODIUM |
| Application number | NDA210632 |
| Sponsor | FRESENIUS KABI USA |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20190411 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →